FGB
Fibrinogen beta chain
Also known as: FIBB_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P02675
- Gene
- FGB
- Ensembl
- ENSG00000171564
- Chromosome
- 4
- Canonical length
- 491 aa
- Protein class
- Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins
- Subcellular location
- Endoplasmic reticulum
- Secretome location
- Secreted to blood
OverviewNCBI Gene
The protein encoded by this gene is the beta component of fibrinogen, a blood-borne glycoprotein comprised of three pairs of nonidentical polypeptide chains. Following vascular injury, fibrinogen is cleaved by thrombin to form fibrin which is the most abundant component of blood clots. In addition, various cleavage products of fibrinogen and fibrin regulate cell adhesion and spreading, display vasoconstrictor and chemotactic activities, and are mitogens for several cell types. Fibrinogen serves key roles in hemostasis and antimicrobial host defense. Mutations in this gene lead to several disorders, including afibrinogenemia, dysfibrinogenemia, hypodysfibrinogenemia and thrombotic tendency. [provided by RefSeq, Aug 2020]
Canonical amino-acid sequenceUniProt
491 residues, UniProt reviewed canonical sequence.
>P02675|FGB
1 MKRMVSWSFH KLKTMKHLLL LLLCVFLVKS QGVNDNEEGF FSARGHRPLD KKREEAPSLR
61 PAPPPISGGG YRARPAKAAA TQKKVERKAP DAGGCLHADP DLGVLCPTGC QLQEALLQQE
121 RPIRNSVDEL NNNVEAVSQT SSSSFQYMYL LKDLWQKRQK QVKDNENVVN EYSSELEKHQ
181 LYIDETVNSN IPTNLRVLRS ILENLRSKIQ KLESDVSAQM EYCRTPCTVS CNIPVVSGKE
241 CEEIIRKGGE TSEMYLIQPD SSVKPYRVYC DMNTENGGWT VIQNRQDGSV DFGRKWDPYK
301 QGFGNVATNT DGKNYCGLPG EYWLGNDKIS QLTRMGPTEL LIEMEDWKGD KVKAHYGGFT
361 VQNEANKYQI SVNKYRGTAG NALMDGASQL MGENRTMTIH NGMFFSTYDR DNDGWLTSDP
421 RKQCSKEDGG GWWYNRCHAA NPNGRYYWGG QYTWDMAKHG TDDGVVWMNW KGSWYSMRKM
481 SMKIRPFFPQ QLocalizationUniProt · AlphaFold · HPA
Whether an antibody against FGB can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.38
- Highest tissue expression
- 16,765 nTPM
Expression across tissuesHPA
Tissue
- liver: 16,765 nTPM
- kidney: 48 nTPM
- spleen: 9.6 nTPM
- stomach: 6.1 nTPM
- pancreas: 3.1 nTPM
- breast: 2.6 nTPM
Single-cell type
- hepatocytes: 17,548 nCPM
- kupffer cells: 229 nCPM
- hepatic stellate cells: 181 nCPM
- cholangiocytes: 112 nCPM
- parietal cells: 73 nCPM
- pancreatic islet cells: 33 nCPM
Immune cell
- neutrophil: 0.2 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- cerebral cortex: 0.4 nTPM
- basal ganglia: 0.3 nTPM
- choroid plexus: 0.3 nTPM
- hypothalamus: 0.3 nTPM
- medulla oblongata: 0.3 nTPM
- pons: 0.3 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about FGB.
Disease | AllUniProt
Conditions FGB is implicated in, by any mechanism.
- Congenital afibrinogenemia (CAFBN) MIM:202400
- Dysfibrinogenemia, congenital (DYSFIBRIN) MIM:616004
Disease | GeneticClinVar
19 pathogenic / likely-pathogenic of 268 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Congenital afibrinogenemia
- Familial dysfibrinogenemia
- FGB-related disorder
- Hypofibrinogenemia
- See cases
Disease | ImmuneIEDB
Conditions an epitope on FGB was assayed in.
- rheumatoid arthritis B and T cell
- myocardial infarction T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.43
- gnomAD pLI
- 0.57
- gnomAD missense Z
- 0.73
- DepMap mean gene effect
- 0.15
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adaptive immune response
- blood coagulation, fibrin clot formation
- cell-matrix adhesion
- cellular response to interleukin-1
- cellular response to leptin stimulus
- fibrinolysis
- induction of bacterial agglutination
- innate immune response
- negative regulation of endothelial cell apoptotic process
- negative regulation of extrinsic apoptotic signaling pathway via death domain receptors
- plasminogen activation
- platelet aggregation
- positive regulation of ERK1 and ERK2 cascade
- positive regulation of exocytosis
- positive regulation of heterotypic cell-cell adhesion
- positive regulation of peptide hormone secretion
- positive regulation of protein secretion
- positive regulation of substrate adhesion-dependent cell spreading
- positive regulation of vasoconstriction
- protein polymerization
- protein-containing complex assembly
- response to calcium ion
Molecular functions
- extracellular matrix structural constituent
- protein-folding chaperone binding
- signaling receptor binding
- structural molecule activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Fibrinogen, alpha/beta/gamma chain, C-terminal globular domain
- Fibrinogen, alpha/beta/gamma chain, coiled coil domain
- Fibrinogen, alpha/beta/gamma chain, C-terminal globular, subdomain 1
- Fibrinogen, conserved site
- Fibrinogen-like, C-terminal
- Fibrinogen/angiopoietin-like
- Fibrinogen beta and gamma chains, C-terminal globular domain
- Fibrinogen alpha/beta chain family
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of FGB in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads FGB as an antibody target. Whether an autoantibody or antibody against FGB could matter depends on whether native FGB is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
FGB is annotated as secreted, so native FGB circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label FGB as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...